Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. [electronic resource]
Producer: 20130603Description: 2315-26 p. digitalISSN:- 1473-5571
- Adult
- Anti-HIV Agents -- pharmacology
- Atherosclerosis -- blood
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Chemokine CCL2 -- blood
- Drug Administration Schedule
- E-Selectin -- metabolism
- Fasting
- Female
- Follow-Up Studies
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- pharmacology
- Humans
- Interleukin-10 -- blood
- Interleukin-6 -- blood
- Lipids -- blood
- Male
- Middle Aged
- Osteoprotegerin -- blood
- P-Selectin -- metabolism
- Pyrrolidinones -- pharmacology
- Raltegravir Potassium
- Ritonavir -- pharmacology
- Tumor Necrosis Factor-alpha -- blood
- Vascular Cell Adhesion Molecule-1 -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.